pharmaphorum

NOVEMBER 16, 2022

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.

Medicine 105

Medicine Production Pharma Companies Licensing 105

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

Pharmaceutical Technology

OCTOBER 28, 2022

Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins. Remote-controlled robotic labs. Lab-specific industrial co-bots can carry out both complex and repetitive tasks such as liquid handling.

Development 311

Development Drugs Pharma Companies Life Science 311

Pharmaceutical Technology

JANUARY 16, 2023

Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

Delveinsight

SEPTEMBER 24, 2021

Pharma companies such as Calliditas Therapeutics AB, Chinook Therapeutics, Inc., Further, the IgAN patient pool is huge and the prevalence is expected to increase in the coming next years that will further attract the pharma and biotech companies to work in the domain. million in 2020 in the 7MM. .

Pharma Companies 77

Pharma Companies Marketing Protein Drugs 77

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

STAT News

FEBRUARY 13, 2023

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche. and a leading researcher in cell biology.

Life Science 98

Life Science Pharma Companies Medicine Research 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

BioTech 365

SEPTEMBER 11, 2020

LONDON–(BUSINESS WIRE)–DrugsDisclosed.com launched today to give patients more control over their own treatments, with a unique service to share real world experiences of their medicines.

Pharma Companies 40

Pharma Companies Research Medicine 40

pharmaphorum

NOVEMBER 5, 2020

Talking Medicines has raised £1.1 million) in funding that will be used to develop an artificial intelligence (AI) data platform that can be used by pharma companies to gain insights into how patients perceive them. To date Talking Medicines has raised £2.5 million ($1.4

Medicine 59

Medicine Pharma Companies Branding Regulation 59

pharmaphorum

FEBRUARY 16, 2021

Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . It reckons its use of AI and machine learning can trim years off the current 12- to 15-year cycle from early research to marketed product.

Research 119

Research Drugs Protein Development 119

The Pharma Data

JANUARY 24, 2021

–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Vickers has over 30 years of experience as a researcher and leader in the pharmaceutical industry.

Medicine 52

Medicine Pharma Companies Gene Therapy Development 52

XTalks

MARCH 31, 2023

BMS researchers on the mission will study the crystallization of an assortment of their biologics medicines in microgravity. By growing high quality crystal structures of protein-based therapeutics under microgravity, researchers can gain better insights into their complex structures and stability.

Protein 97

Protein Research Development Manufacturing 97

World of DTC Marketing

JANUARY 4, 2022

They told the researchers that insurance didn’t protect them from serious money problems. According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. (Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S.

Pharma Companies 273

Pharma Companies Drugs Medicine Research 273

Drug Discovery World

FEBRUARY 5, 2024

One-third (32%) of rare disease patients are not aware they can access unlicensed medicines through Early Access Programmes, new research has revealed. However, two-thirds (68%) of patients are comfortable receiving medicines before they’re licensed through their country’s healthcare system.

Medicine 52

Medicine Pharma Companies Licensing Licensing 52

Pharmaceutical Technology

JULY 21, 2022

In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. In response to the Ukraine crisis, many pharma companies are ensuring a supply of essential medicine to Ukraine and surrounding countries.

Pharma Companies 130

Pharma Companies Clinical Trials Clinical Trials Drugs 130

pharmaphorum

SEPTEMBER 29, 2020

Within the last two decades, large pharmaceutical corporations have established themselves firmly in oncology by prioritising internal R&D efforts, as well as developing and accessing novel science and technology through collaborations and alliances with biotech companies and academic institutions.

Research 132

Research Gene Editing Gene Development 132

Pharma Marketing Network

SEPTEMBER 6, 2023

This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies.

Research 64

Research Marketing Pharma Companies Branding 64

Fossil Remedies

JULY 15, 2022

As the number of people affected by these problems is increasing, there is a high demand for medicines required to treat them. If you are planning to launch Cardiac Diabetic PCD Pharma Franchise, then it is the best time. You need an ISO-confirmed company that has WHO and GMP certification also.

Pharma Companies 52

Pharma Companies Packaging Packaging Medicine 52

World of DTC Marketing

APRIL 14, 2021

BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money.

Pharma Companies 191

Pharma Companies Vaccination Vaccine Sales 191

World of DTC Marketing

AUGUST 29, 2022

A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. The research showed that patients wanted to understand how the drug works and the potential side effects.

Branding 203

Branding Marketing Pharma Companies Doctors 203

Drug Discovery World

SEPTEMBER 11, 2023

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. The post Pharma must embrace an AI future says new report appeared first on Drug Discovery World (DDW).

Pharma Companies 57

Pharma Companies Marketing Drugs Medicine 57

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

Pharmaceutical Technology

JUNE 30, 2022

Nonprofits like the Drugs for Neglected Diseases initiative (DNDi) and independent researchers are studying diseases such as river blindness, which are missing more targeted and effective treatments. However, some big pharma players have a history of donating some treatments to the cause, he explains. For example, Merck & Co.

Pharma Companies 162

Pharma Companies FDA Approval Development Drugs 162

Pharma Marketing Network

SEPTEMBER 6, 2023

This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies.

Research 52

Research Marketing Pharma Companies Branding 52

Pharmaceutical Technology

MAY 17, 2023

However, Randy Burkholder, vice president of policy and research for the industry group Pharmaceutical Research and Manufacturers of America (PhRMA), said this provision amounted to government “price setting” that would harm future research and development efforts.

Insulin 130

Insulin Drugs Pharma Companies Manufacturing 130

World of DTC Marketing

MARCH 11, 2022

healthcare system significantly declined during the pandemic , along with their confidence in the leaders and executives at the healthcare organizations employing them, according to a report from the nonpartisan research group NORC at the University of Chicago commissioned by the ABIM Foundation. Physician trust in the U.S.

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. UCB completed six months’ worth of computational screening and compound design in three days using the technology.

Drugs 97

Drugs Medicine Pharma Companies Clinical Development 97

pharmaphorum

DECEMBER 15, 2021

For their parts, patient advocates share survey results with drug companies or recruit patients and caregivers to speak about the nature of their diseases and existing treatments. Second—and closely related to the first transformation—patient centricity requires new kinds of relationships between industry and patient advocacy groups.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

World of DTC Marketing

MAY 19, 2021

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. A “critical part” of pharmaceutical company AbbVie ‘s success is “face-to-face” interaction, CEO Richard Gonzalez explained in an Aug. 27 email outlining its process for bringing thousands of U.S.

Pharma Companies 181

Pharma Companies Drugs Branding Manufacturing 181

pharmaphorum

JANUARY 12, 2023

” At the heart of the initiative is the inescapable fact that pharma companies have to spend around 15% of their sales on R&D, but new drugs can take years to develop and billions of dollars in investment. Image source: Google. The post Bayer taps Google’s quantum power for drug discovery appeared first on.

Drugs 122

Drugs Protein Pharma Companies Sales 122

World of DTC Marketing

AUGUST 10, 2021

SUMMARY : Falsehoods have been shown to spread faster and farther than accurate information, and research suggests that misinformation can have negative effects in the real world, such as amplifying controversy about vaccines and propagating unproven cancer treatments.

Production 180

Production Pharma Companies Doctors Doctor 180

Drug Discovery World

DECEMBER 14, 2023

The new centre represents a flagship investment within the University’s Glasgow Riverside Innovation District (GRID) and will be home to commercial businesses as well as the University of Glasgow-led Living Laboratory for Precision Medicine.

Drugs 73

Drugs Life Science Research Scientist 73

Drug Discovery World

JANUARY 25, 2024

Japan-based pharma company Kyowa Kirin has successfully completed the acquisition of gene therapy developer Orchard Therapeutics. Libmeldy is approved by the European Commission (EC) and UK Medicines and Healthcare products Regulatory Agency (MHRA).

Gene Therapy 52

Gene Therapy Gene Pharma Companies Drugs 52

World of DTC Marketing

JANUARY 24, 2022

To them, a big payday is a small biotech firm being acquired by a big ten pharma company. When they tell small biotech companies to cut costs, there will often be a significant delay in getting the drug to market or massive layoffs of needed staff. Venture capitalists often don’t look that far forward. Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

Pharmaceutical Technology

SEPTEMBER 2, 2022

This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie. lenalidomide) + a steroid ± an anti-CD38 antibody.

Antibody 147

Antibody Sales FDA Approval Production 147

pharmaphorum

JANUARY 25, 2022

Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical research internationally. The company is tapping into longstanding concerns in the life science industry about R&D productivity.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52